6.
. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990; 21(4):637-76.
DOI: 10.1161/01.str.21.4.637.
View
7.
Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N
. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005; 20(6):1048-56.
DOI: 10.1093/ndt/gfh813.
View
8.
Rothwell P, Warlow C
. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005; 64(5):817-20.
DOI: 10.1212/01.WNL.0000152985.32732.EE.
View
9.
Siru R, Conradie J, Gillett M, Page M
. Approach to the diagnosis of secondary hypertension in adults. Aust Prescr. 2021; 44(5):165-169.
PMC: 8542481.
DOI: 10.18773/austprescr.2021.038.
View
10.
Heron N, OConnor S, Kee F, Thompson D, Anderson N, Cutting D
. Development of a Digital Lifestyle Modification Intervention for Use after Transient Ischaemic Attack or Minor Stroke: A Person-Based Approach. Int J Environ Res Public Health. 2021; 18(9).
PMC: 8124154.
DOI: 10.3390/ijerph18094861.
View
11.
Mokbel K, Daniels R, Weedon M, Jackson L
. A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England. In Vivo. 2022; 36(2):780-800.
PMC: 8931874.
DOI: 10.21873/invivo.12765.
View
12.
Drescher C, Buchwald F, Ullberg T, Pihlsgard M, Norrving B, Petersson J
. Epidemiology of First and Recurrent Ischemic Stroke in Sweden 2010-2019: A Riksstroke Study. Neuroepidemiology. 2022; 56(6):433-442.
PMC: 9945185.
DOI: 10.1159/000527373.
View
13.
Mantel-Teeuwisse A, Goettsch W, Klungel O, de Boer A, Herings R
. Long term persistence with statin treatment in daily medical practice. Heart. 2004; 90(9):1065-6.
PMC: 1768444.
DOI: 10.1136/hrt.2003.026187.
View
14.
von Weitzel-Mudersbach P, Andersen G, Hundborg H, Johnsen S
. Transient ischemic attack and minor stroke are the most common manifestations of acute cerebrovascular disease: a prospective, population-based study--the Aarhus TIA study. Neuroepidemiology. 2012; 40(1):50-5.
DOI: 10.1159/000341696.
View
15.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M
. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337.
DOI: 10.1093/eurheartj/ehab484.
View
16.
Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C
. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... Circulation. 2018; 138(17):e484-e594.
DOI: 10.1161/CIR.0000000000000596.
View
17.
Ovbiagele B, Kidwell C, Saver J
. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke. 2003; 34(4):919-24.
DOI: 10.1161/01.STR.0000064323.65539.A7.
View
18.
Aggarwal D, Bhatia K, Chunawala Z, Furtado R, Mukherjee D, Dixon S
. P2Y inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials. Eur Heart J Open. 2022; 2(2):oeac019.
PMC: 9242055.
DOI: 10.1093/ehjopen/oeac019.
View
19.
Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A
. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal.... J Hypertens. 2023; 41(12):1874-2071.
DOI: 10.1097/HJH.0000000000003480.
View
20.
Diamond D, Ravnskov U
. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol. 2015; 8(2):201-10.
DOI: 10.1586/17512433.2015.1012494.
View